51. Acute Kidney Injury in Children: A Focus for the General Pediatrician.
- Author
-
Rivetti, Giulio, Gizzone, Pietro, Petrone, Delfina, Di Sessa, Anna, Miraglia del Giudice, Emanuele, Guarino, Stefano, and Marzuillo, Pierluigi
- Subjects
ACUTE kidney failure prevention ,FUROSEMIDE ,BUMETANIDE ,HEALTH ,DISEASE management ,ACUTE kidney failure in children ,INFORMATION resources ,ACUTE kidney failure ,THEOPHYLLINE ,OXIDOREDUCTASES ,CHILD care ,DOPAMINE ,FENOLDOPAM (Drug) ,BIOMARKERS ,SYMPTOMS ,CHILDREN - Abstract
Acute kidney injury (AKI) presents significant challenges in pediatric care, often remaining underrecognized. This paper provides an overview of pediatric AKI, highlighting its epidemiology, pathophysiology, diagnosis, predisposing conditions, and treatment. AKI in children stems from diverse causes, including renal tubular damage, vasoconstriction, and inflammation. Diagnosis relies on traditional markers such as serum creatinine and urine output, alongside emerging biomarkers such as Cystatin C, NGAL, KIM-1, IL-18, TIMP-2 and IGFBP7, urinary calprotectin, URBP4, L-FABP, and clusterin. Various pediatric conditions predispose to AKI, including type 1 diabetes, pneumonia, bronchiolitis, appendicitis, gastroenteritis, COVID-19, multisystem inflammatory syndrome, sickle cell disease, and malignancies. Treatment entails supportive care with fluid management and, in severe cases, renal replacement therapy. Timely recognition and management are essential to mitigating adverse outcomes. Enhanced awareness and integration of novel biomarkers could improve pediatric AKI care, warranting further research for better diagnosis and management. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF